|
| | Issue Date | Title | Author(s) |
| 1 | 2026 | MGMT, NUPR1, NDRG2, and GLI1 Gene Promoter Methylation in Glioblastoma Tissues and Association with Clinical Characteristics and Therapeutic Outcomes | Gabr, Mariam M.; AbdelHamid, Sherihan G.; Ezz Elarab, Lobna ; Swellam, Menha; Prof. Hamdy, Nadia M. |
| 2 | 1-Dec-2025 | Expression of some circulating microRNAs as predictive biomarkers for prognosis and treatment response in glioblastoma | Ali, Elham; Ahmed, Marwa Adel; Shawki, May A.; Ezz Elarab, Lobna ; Swellam, Menha; Khalifa K. E. |
| 3 | 1-Oct-2024 | Tailoring neoadjuvant systemic therapy in breast cancer: “The advent of a personalized approach”—The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations | Elghazaly, Hesham; Azim, Hamdy A.; Rugo, Hope S.; Cameron, David; Swain, Sandra M.; Curigliano, Giuseppe; Harbeck, Nadia; Tripathy, Debu; Arun, Banu; Aapro, Matti; Piccart, Martine; Cardoso, Fatima; Gligorov, Joseph; El Saghir, Nagi S.; Penault-Llorca, Frederique; Perez, Edith A.; Poortmans, Philip; Abdelaziz, Hany; El-Zawahry, Heba M.; Kassem, Loay; Viale, Giuseppe; Al-Sukhun, Sana; Gado, Neven; Leung, Jessica W.T.; Ezz Elarab, Lobna ; Cardoso, Maria João; Foheidi, Meteb; Elmaadawy, Merit M.; Conte, Pierfranco; Selim, Ashraf S.M.; Kandil, Alaa; Kamal, Rasha M.; Paltuev, Ruslan M.; Guarneri, Valentina; Abulkhair, Omalkhair; Zakaria, Omar; Golshan, Mehra; Orecchia, Roberto; ElMahdy, Manal; Abdel-Aziz, Ahmed M.; Eldin, Nermean Bahie; Abdel Karim, Khaled; Elghazawy, Hagar; Sabry, Mohamed-Nabil |
| 4 | 1-Jan-2024 | Clinical role of NDRG2-based methylation status on survival pattern of glioblastoma | Swellam, Menha; Nageeb, Amira M.; Ezz Elarab, Lobna ; El-Mahdy, Manal; El-Bahy, Khaled; Sayed Mahmoud, Magda; Khalifa K. E. |
| 5 | 2024 | Association between Cytochrome P450 Genetic Polymorphism and Hematological Toxicity of Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP Protocol | Roshdy, Mohamed; Swellam, menha; Mohamed, Magdy ; Ezz Elarab, Lobna ; Mohamed, Rania; Abd El Kader, Nour M |
| 6 | 1-Dec-2023 | Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma | Ebid, Osama Abd El Hameed; Ezz Elarab, Lobna ; Saad, Amr S.; Ezz El Din, Mai; Mostafa, Nermeen; Swellam, Menha |
| 7 | 1-Oct-2023 | Rheumatological manifestations in patients with malignancies: Relation to immune modulation therapy | Elshahat, Nouran M.; Mansour, Howaida E.; BadrEldin, Amina; Abdel Rahman, Maryam A.; Ezz Elarab, Lobna ; Aziz, Nermeen N. |
| 8 | Aug-2022 | Relevance of circulating MiRNA-21 and MiRNA-181 in prediction of glioblastoma multiforme prognosis | Labib, Esraa M; Ezz Elarab, Lobna ; Ghanem, Hala M; Hassan, Rasha E; Swellam, Menha |
| 9 | 1-Jul-2022 | Prognostic utility of lncRNAs (LINC00565 and LINC00641) as molecular markers in glioblastoma multiforme (GBM) | Amer, Rehab G.; Ezz Elarab, Lobna ; Abd El Ghany, Dalia; Saad, Amr S.; Bahie-Eldin, Nermean; Swellam, Menha |
| 10 | Jun-2022 | Next generation sequencing of BRCA genes in glioblastoma multiform Egyptian patients: a pilot study | Nageeb, Amira M; Mohamed, Magdy ; Ezz Elarab, Lobna ; Swellam, Menha; Khalifa K. E. |
| 11 | 1-Aug-2021 | The first BGICC consensus and recommendations for breast cancer awareness, early detection and risk reduction in low- and middle-income countries and the MENA region | Elghazaly, Hesham; Aref, Adel T.; Anderson, Benjamin O.; Arun, Banu; Yip, Cheng Har; Abdelaziz, Hany; Ghosn, Marwan; Al-Foheidi, Meteb; Cardenosa, Gilda; Leung, Jessica W.T.; Gado, Nivine; Balch, Charles M.; Sabry, Mohamed-Nabil ; Ezz Elarab, Lobna ; Giuliano, Armando E.; El-Zawahry, Heba M.; Abdel Karim, Khaled ; Nasr, Azza; Maki, Hussein; Chung, Hannah; Saadeddin, Ahmed; Abdelwahab, Manal M.; Al Tahan, Fatina M.; Chalabi, Nivine; Frolova, Mona; Kamal, Rasha M.; Shehata, Mohamed A.; Bahie Eldin, Nermean; Elghazawy, Hagar |
| 12 | 1-Aug-2021 | The first BGICC consensus and recommendations for breast cancer awareness, early detection and risk reduction in low- and middle-income countries and the MENA region | Elghazaly, Hesham; Aref, Adel T.; Anderson, Benjamin O.; Arun, Banu; Yip, Cheng Har; Abdelaziz, Hany; Ghosn, Marwan; Al-Foheidi, Meteb; Cardenosa, Gilda; Leung, Jessica W.T.; Gado, Nivine; Balch, Charles M.; Ezz Elarab, Lobna ; Giuliano, Armando E.; El-Zawahry, Heba M.; Abdel Karim, Khaled ; Nasr, Azza; Maki, Hussein; Chung, Hannah; Saadeddin, Ahmed; Abdelwahab, Manal M.; Al Tahan, Fatina M.; Chalabi, Nivine; Frolova, Mona; Kamal, Rasha M.; Shehata, Mohamed A.; Bahie Eldin, Nermean; Elghazawy, Hagar ; Sabry, Mohamed-Nabil |
| 13 | 1-Aug-2021 | The first BGICC consensus and recommendations for breast cancer awareness, early detection and risk reduction in low- and middle-income countries and the MENA region | Elghazaly, Hesham; Aref, Adel T.; Anderson, Benjamin O.; Arun, Banu; Yip, Cheng Har; Abdelaziz, Hany; Ghosn, Marwan; Al-Foheidi, Meteb; Cardenosa, Gilda; Leung, Jessica W.T.; Gado, Nivine; Balch, Charles M.; Ezz Elarab, Lobna ; Giuliano, Armando E.; El-Zawahry, Heba M.; Nasr, Azza; Maki, Hussein; Chung, Hannah; Saadeddin, Ahmed; Abdelwahab, Manal M.; Al Tahan, Fatina M.; Chalabi, Nivine; Frolova, Mona; Kamal, Rasha M.; Shehata, Mohamed A.; Bahie Eldin, Nermean; Abdel Karim, Khaled; Elghazawy, Hagar; Sabry, Mohamed-Nabil |
| 14 | 1-May-2021 | Clinical recommendations in the management of advanced prostate cancer: International Gastrointestinal, Liver and Uro-oncology (IGILUC 2019) experts | Elghazaly, Hesham; Mottet, Nicolas; Garcia, Jorge; Oudard, Stephane; Roach, Mack; Abbou, Claude; Merseburger, Axel; Emara, Amr; Shehata, Samir; Tawfik, Hesham; Khorshid, Ola; Selim, Ahmed; Assem, Akram; Abdelkarim, Khalid; Ezz Elarab, Lobna ; Bazarbashi, Shouki; Omar, Abbass; Elwakil, Hesham; Elashry, Mohamed; Abou ElFotouh, Mohamed; Osman, Tarek; Ezz El Din, Mai |
| 15 | 1-Apr-2021 | Emerging role of miRNAs as liquid biopsy markers for prediction of glioblastoma multiforme prognosis | Swellam, Menha; Bakr, Noha M.; El Magdoub, Hekmat M.; Hamza, Marwa S.; LlobnaR.Ezz Elarab |
| 16 | 1-Sep-2019 | Clinical impact of circulating oncogenic MiRNA-221 and MiRNA-222 in glioblastoma multiform | Swellam, Menha; Ezz Elarab, Lobna ; Al-Posttany, Amr S.; B. Said, Samy |
| 17 | 15-Dec-2015 | Clinical Significance of Serum IL-12 Level in Patients with Early Breast Carcinoma and Its Correlation with Other Tumor Markers | Youssef, Samar Samir; Mohammad, Manal Moussa; Ezz Elarab, Lobna |
| 18 | 1-Jan-2014 | Clinical implications of proteolytic activity imbalance in breast cancer diagnosis | Swellam, Menha; Soliman, Hanan A.; Abdelmaksoud, Mohamed D.E.; Nageeb, Amira M.; Ezz Elarab, Lobna ; Boshnak, Hussein |
| 19 | 1-Jan-2014 | Clinical implications of proteolytic activity imbalance in breast cancer diagnosis | Swellam, Menha; Soliman, Hanan A.; Abdelmaksoud, Mohamed D.E.; Nageeb, Amira M.; LlobnaR.Ezz Elarab ; Boshnak, Hussein |
| 20 | 1-Mar-2012 | Temozolomide and radiotherapy in newly diagnosed glioblastoma patients: O 6-methylguanine-DNA methyltransferase (MGMT) promotor methylation status and Ki-67 as biomarkers for survival and response to treatment | Karim, K. Abdel; El Mahdy, M. M.; Wahab, M. M.Abdel; Ezz Elarab, Lobna ; El Shehaby, A.; Raouf, S. Abdel |